Metabolic tumor burden as a prognostic indicator after neoadjuvant chemotherapy in pancreatic cancer.
Lee W, Oh M, Kim JS, Sung M, Hong K, Kwak BJ, Park Y, Jun E, Song KB, Hwang DW, Lee JH, Yoo C, Kim KP, Park I, Jeong JH, Chang HM, Ryoo BY, Lee JB, Kim SC.
Lee W, et al. Among authors: hwang dw.
Int J Surg. 2024 Mar 28. doi: 10.1097/JS9.0000000000001389. Online ahead of print.
Int J Surg. 2024.
PMID: 38537071